JP2007535668A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535668A5 JP2007535668A5 JP2007509977A JP2007509977A JP2007535668A5 JP 2007535668 A5 JP2007535668 A5 JP 2007535668A5 JP 2007509977 A JP2007509977 A JP 2007509977A JP 2007509977 A JP2007509977 A JP 2007509977A JP 2007535668 A5 JP2007535668 A5 JP 2007535668A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- analyte
- antibody
- cell
- support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 21
- 239000003795 chemical substances by application Substances 0.000 claims 17
- 239000012491 analyte Substances 0.000 claims 14
- 210000004027 cell Anatomy 0.000 claims 10
- 238000003556 assay Methods 0.000 claims 7
- 230000028327 secretion Effects 0.000 claims 7
- 230000002708 enhancing effect Effects 0.000 claims 5
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 4
- 108090000695 Cytokines Proteins 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000003248 secreting effect Effects 0.000 claims 3
- 230000004936 stimulating effect Effects 0.000 claims 3
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 2
- 229940126530 T cell activator Drugs 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 1
- -1 ICOS Proteins 0.000 claims 1
- 108010065805 Interleukin-12 Proteins 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 239000000020 Nitrocellulose Substances 0.000 claims 1
- 239000002033 PVDF binder Substances 0.000 claims 1
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 229920001220 nitrocellulos Polymers 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0409775.4A GB0409775D0 (en) | 2004-04-30 | 2004-04-30 | Assay |
| GB0409775.4 | 2004-04-30 | ||
| PCT/EP2005/004620 WO2005106479A1 (en) | 2004-04-30 | 2005-04-29 | Non-elispot assay |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007535668A JP2007535668A (ja) | 2007-12-06 |
| JP2007535668A5 true JP2007535668A5 (enExample) | 2008-06-19 |
| JP4990129B2 JP4990129B2 (ja) | 2012-08-01 |
Family
ID=32482521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509977A Expired - Fee Related JP4990129B2 (ja) | 2004-04-30 | 2005-04-29 | 非ＥＬＩＳｐｏｔアッセイ法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8790872B2 (enExample) |
| EP (1) | EP1740949B1 (enExample) |
| JP (1) | JP4990129B2 (enExample) |
| AT (1) | ATE533053T1 (enExample) |
| AU (1) | AU2005238635B2 (enExample) |
| CA (1) | CA2564826C (enExample) |
| GB (1) | GB0409775D0 (enExample) |
| WO (1) | WO2005106479A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0409771D0 (en) * | 2004-04-30 | 2004-06-09 | Mabtech Ab | Assay |
| EP1867988A1 (en) * | 2006-06-12 | 2007-12-19 | Centro Biotecnologie Avanzate | Cytokine capture assay in high throughput format for determining antigen-specific T-cell responses |
| PT2367561E (pt) | 2008-11-30 | 2015-10-23 | Immusant Inc | Composições e métodos para o tratamento da doença celíaca |
| WO2014115102A1 (en) * | 2013-01-23 | 2014-07-31 | Institut National De La Sante Et De La Recherche Medicale | Number of il4 and/or il3 secreting t-cells as a biomarker for allergic diseases |
| WO2015038624A1 (en) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage of a gluten peptide composition |
| US10370718B2 (en) | 2014-09-29 | 2019-08-06 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI76888C (fi) | 1981-04-29 | 1988-12-12 | Ciba Geigy Ag | Nya medel och foerpackningar foer immunologiska analyser. |
| US4591570A (en) | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
| GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| SE465943B (sv) * | 1988-10-14 | 1991-11-18 | Virovahl Sa | Metod foer samtidig detektering av olika analyter, spec antikroppar med "elispot" tekniken |
| EP0438457A1 (en) | 1988-10-14 | 1991-07-31 | Syntello Ab | A method for simultaneous detection of different types of antibodies and/or antigens produced by individual cells |
| FR2679659B1 (fr) | 1991-07-23 | 1993-11-19 | Medgenix Diagnostic Sa | Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte. |
| US6410252B1 (en) | 1995-12-22 | 2002-06-25 | Case Western Reserve University | Methods for measuring T cell cytokines |
| DE19821289A1 (de) | 1998-05-13 | 1999-11-18 | Volkmar Schoellhorn | Verfahren zur Bestimmung der Aktivität von menschlichen und tierischen Zellen, insbesondere Blutzellen, und Mikrotiterplatten |
| JP2003511696A (ja) | 1999-10-13 | 2003-03-25 | インサイト・ゲノミックス・インコーポレイテッド | 多重的サイトカイン分析 |
| AU2002305914A1 (en) | 2001-01-12 | 2002-10-21 | Chiron Corporation | Nucleic acid mucosal immunization |
| EP1241476A1 (en) | 2001-03-12 | 2002-09-18 | Mabtech AB | Diagnosis of metal allergy through cytokine release by T-cells in vitro |
| WO2003023360A2 (en) | 2001-09-10 | 2003-03-20 | Meso Scale Technologies, Llc | Methods and apparatus for conducting multiple measurements on a sample |
| AU2002342299A1 (en) | 2001-10-31 | 2003-05-12 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of | Generation of use of tc1 and tc2 cells |
| AU2003221073B2 (en) * | 2002-03-25 | 2008-08-21 | Takara Bio Inc. | Process for producing cytotoxic lymphocyte |
| US20040049351A1 (en) | 2002-08-28 | 2004-03-11 | Matson Robert S. | Immunosorbent assay in microarray format |
| US20060079461A1 (en) | 2003-12-24 | 2006-04-13 | Scios, Inc. | Treatment of multiple myeloma by inhibition of p38 MAP kinase |
| GB0409771D0 (en) | 2004-04-30 | 2004-06-09 | Mabtech Ab | Assay |
-
2004
- 2004-04-30 GB GBGB0409775.4A patent/GB0409775D0/en not_active Ceased
-
2005
- 2005-04-29 JP JP2007509977A patent/JP4990129B2/ja not_active Expired - Fee Related
- 2005-04-29 AT AT05736132T patent/ATE533053T1/de active
- 2005-04-29 EP EP05736132A patent/EP1740949B1/en not_active Expired - Lifetime
- 2005-04-29 AU AU2005238635A patent/AU2005238635B2/en not_active Ceased
- 2005-04-29 US US11/587,545 patent/US8790872B2/en not_active Expired - Fee Related
- 2005-04-29 CA CA2564826A patent/CA2564826C/en not_active Expired - Fee Related
- 2005-04-29 WO PCT/EP2005/004620 patent/WO2005106479A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Santopaolo et al. | Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months | |
| Zhu et al. | A microdevice for multiplexed detection of T-cell-secreted cytokines | |
| JP5675638B2 (ja) | アレルギー反応を診断するための方法 | |
| JP4094674B2 (ja) | ペプチド特異的т細胞のアッセイ方法 | |
| JP5331337B2 (ja) | ＣｕｌｔｉＳｐｏｔアッセイ法 | |
| Spoerl et al. | Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection | |
| JP2012515548A5 (enExample) | ||
| AU2007228598A1 (en) | Clinical correlates | |
| JP2007535668A5 (enExample) | ||
| Ning et al. | Evaluation of SARS-CoV-2-specific T-cell activation with a rapid on-chip IGRA | |
| CN101868724A (zh) | 用于体外诊断和/或体外治疗监测感染的方法 | |
| EP1740949B1 (en) | Non-elispot assay | |
| CN101799474B (zh) | 一种检测重组人白细胞介素-12蛋白活性的方法 | |
| TWI753442B (zh) | 一種體外活化免疫細胞之方法 | |
| CN204989188U (zh) | 评价机体免疫能力试剂盒 | |
| Garibay-Escobar et al. | Integrated measurements by flow cytometry of the cytokines IL-2, IFN-γ, IL-12, TNF-α and functional evaluation of their receptors in human blood | |
| RU2781235C1 (ru) | Способ определения наличия реакции Т-клеток в крови человека на присутствие антигенов SARS-CoV2 | |
| CN116102629B (zh) | 一种结核分枝杆菌t细胞抗原表位多肽及其应用 | |
| Berrong et al. | Methods for Detection of Antigen‐Specific T Cells by Enzyme‐Linked Immunospot Assay | |
| EP4573367A2 (en) | Point-of-care on-chip igra device and method for measuring specific t cell activation | |
| Shacklett et al. | Methods for Detection of Antigen‐Specific T Cells by Enzyme‐Linked Immunospot Assay (ELISPOT) | |
| TW202144568A (zh) | 一種用於體外活化免疫細胞之培養基 | |
| Jagannadha Sastry et al. | Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques | |
| WO2022103351A1 (en) | Laboratory and clinical test method for the follow-up of t cell response in the diagnosis and monitoring of covid 19 disease | |
| Cunningham-Rundles | 9 Methodological Issues in Assessment of Human Immune Function |